Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Director's Dealing 2009

Jun 18, 2009

65044_rns_2009-06-18_ed69f481-4679-4615-ad2a-decb3f408359.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

ASX RELEASE

19 June 2009

==> picture [151 x 53] intentionally omitted <==

Appendix 3Y‐ Ravindran Govindan

The enclosed Appendix 3Y reflects the change of interest in the company by Director Ravindran Govindan arising from the recent rights issue undertaken by the Company.

In the course of preparing this notice, it was noted that an amount of 200,000 ordinary shares, that were acquired on 5 June 2008, had been omitted from notification to the ASX.

At the time of lodging the Appendix 3Z on 30 May 2008, it had been assumed that from all brokers statements on hand at that time that the total number of ordinary shares acquired by him was 13,467,286 , however due to an oversight, an additional 200,000 were settled on 5 June 2008.

Accordingly, the attached Appendix 3Y reflects the notification of the acquisition of the additional 200,000 on 5 June 2008 and not previously notified to the ASX.

The Company’s directors are fully aware of their obligations to report changes in holdings and this arose through administrative oversight.

Alan Boys Company Secretary CollTech Australia Limited

About CollTech

CollTech Australia Limited is an ASX‐listed (ASX: CAU) bio‐industrial company based in Perth, Western Australia. CollTech specialises in the development and commercialisation of ovine collagen products and is currently the only company in the world manufacturing and marketing this type of collagen. CollTech’s OVICOLL® ovine collagen has several advantages over its bovine, porcine, ‘plant’ and marine competitors including:

  • Disease‐free – sourced from certified and fully traceable livestock

  • Culturally acceptable and Halal certified – there is no known cultural or religious group that objects to the use of ovine products

  • High purity and thermal stability – optimises function and reduces impurities

The company currently markets OVICOLL®|C and OVICOLL®|Clear for cosmetic applications and OVICOLL®|R for research applications.

Enquiries:

Stephen Carter Non‐Executive Chairman P: +618 9426 3900 E: [email protected]

Alan Boys Company Secretary P: +618 9386 4003

E: [email protected]

CollTech Australia Ltd | ABN 24 094 515 992 PO Box 1661 Osborne Park WA 6916 Australia P +618 9426 3900 | F +618 9426 3909 | W www.colltech.com.au | E [email protected]

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity: CollTech Australia Limited

ABN: 24 094 515 992

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr. Ravindran Govindan
Date of last notice 11 November 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change A) 5 June 2008
B) 17 June 2009
No. of securities held prior to change Ordinary Shares – 13,467,286
Listed options (Exp 31/10/09) 7,433,490
Unlisted Options Expiring 23/10/2011
with exercise price of 4 cents
Class Ordinary Shares
Number acquired A) 200,000
B) 6,943,911
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
A)$5,226
B) $69,439
No. of securities held after change 20,611,197 shares
7,433,490
listed
options
(Exp
31/10/2009)
2,000,000
unlisted
options
(Exp
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Nature of change A) On market (refer note attached) Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back B) Pursuant to rights issue

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002